News & Updates

Children and adolescents with Tourette syndrome (TS) may benefit from ecopipam, a first-in-class selective dopamine-1 (D1) receptor antagonist, as it reduced the number of tics and level of daily interference in a post hoc analysis of the phase IIb D1AMOND trial.

There is no short supply of standardized treatment protocols (STPs) for hypertension across the globe, but many of these can be further improved through interventions targeting alignment with the latest evidence-based guidelines and engagement with multiple stakeholders, suggests a study.

A recent systematic review and meta-analysis reveals a considerable burden of otitis media (OM) in China that is often overlooked. At present, the most common bacterial pathogen identified is Streptococcus pneumoniae (S pneumoniae).

A pilot study presented at AAN 2024 revealed that a tandem cycling programme may improve the overall health and wellbeing of individuals with Parkinson’s disease (PD) and their care partners.